Japanese guidelines for the management of pemphigus

Masayuki Amagai, Akiko Tanikawa, Tomoko Shimizu, Takashi Hashimoto, Shigaku Ikeda, Michiko Kurosawa, Hironori Niizeki, Yumi Aoyama, Keiji Iwatsuki, Yasuo Kitajima

Research output: Contribution to journalReview articlepeer-review

71 Citations (Scopus)


The Committee for Guidelines for the Management of Pemphigus was organized as one element of the Japanese Dermatological Association (JDA) and the Ministry of Health, Labour, and Welfare (MHLW) Research Project on Measures for Research Committee for Intractable Skin Disease. Pemphigus has been defined as a group of intractable autoimmune blistering diseases caused by anti-desmoglein 1 and/or anti-desmoglein 3 IgG autoantibodies by the MHLW. The diagnosis of this condition and the criteria for assessing its severity are based on suggestions from the MHLW Research Group. The clinical practice guidelines presented here are those that are currently recommended in Japan. However, symptoms and complications can vary widely among individual pemphigus patients, so not all therapies will be required to be in complete agreement with these guidelines.

Original languageEnglish
Pages (from-to)471-486
Number of pages16
JournalJournal of Dermatology
Issue number6
Publication statusPublished - Jun 2014


  • autoantibody
  • desmoglein
  • diagnosis
  • therapy

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Japanese guidelines for the management of pemphigus'. Together they form a unique fingerprint.

Cite this